Traws Pharma, Inc.

TRAW

$0.57

+4.70%

N/A+$0.03

Healthcare

Biotechnology

NASDAQ

Active Trading

Traws Pharma, Inc., a biopharmaceutical firm in the clinical development stage, is dedicated to creating novel small-molecule medications delivered orally to combat ...

Insider Transactions of TRAW

Acquisitions (A)

Since Jul 9, 2026

Disposals (D)

Since Jul 9, 2026

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Insider Trading Snapshot

Date	Executive	Title	Security	Side	Shares	Price
Jul 9, 2026	Pauza Charles David	officer: Chief Science Officer Virology	Stock Option (right to buy)	A	97,000	$0.68
Jul 9, 2026	CAUTREELS WERNER	director	Stock Option (right to buy)	A	14,150	$0.68
Jul 9, 2026	Savchuk Nikolay	director, officer: Chief Operating Officer	Stock Option (right to buy)	A	93,000	$0.68
Jul 9, 2026	STOVER JACK E	director	Stock Option (right to buy)	A	14,150	$0.68
Jul 9, 2026	Dukes Iain D.	director, officer: Chief Executive Officer	Stock Option (right to buy)	A	274,000	$0.68

Insider Trading Snapshot

Acquisitions (A)

Disposals (D)

Total Shares Bought

708,750

Total Shares Sold

Monthly Insider Activity

Monthly shares of acquisitions/disposals with close price trend (shared daily price source)

Transactions by Title - Shares

X-axis: shares, sorted by total shares desc

Transactions by Title - Counts

X-axis: counts, sorted by A+D counts desc

Key People: Buy/Sell Activity and Price

Dukes Iain D.

director, officer: Chief Executive Officer • 1 txns

Pauza Charles David

officer: Chief Science Officer Virology • 1 txns

CAUTREELS WERNER

director • 1 txns

Savchuk Nikolay

director, officer: Chief Operating Officer • 1 txns

Transactions Table

Date	Executive	Title	Security	Side	Shares	Price	Value
Jul 9, 2026	Pauza Charles David	officer: Chief Science Officer Virology	Stock Option (right to buy)	A	97,000	$0.68	$65,960.00
Jul 9, 2026	CAUTREELS WERNER	director	Stock Option (right to buy)	A	14,150	$0.68	$9,622.00
Jul 9, 2026	Savchuk Nikolay	director, officer: Chief Operating Officer	Stock Option (right to buy)	A	93,000	$0.68	$63,240.00
Jul 9, 2026	STOVER JACK E	director	Stock Option (right to buy)	A	14,150	$0.68	$9,622.00
Jul 9, 2026	Dukes Iain D.	director, officer: Chief Executive Officer	Stock Option (right to buy)	A	274,000	$0.68	$186,320.00
Jul 9, 2026	Redfield Robert	officer: Chief Medical Officer	Stock Option (right to buy)	A	84,000	$0.68	$57,120.00
Jul 9, 2026	Parker Charles Nolan	officer: Chief Financial Officer	Stock Option (right to buy)	A	90,000	$0.68	$61,200.00
Jul 9, 2026	Shoemaker Mary Teresa	director	Stock Option (right to buy)	A	14,150	$0.68	$9,622.00
Jul 9, 2026	Clarke Trafford	director	Stock Option (right to buy)	A	14,150	$0.68	$9,622.00
Jul 9, 2026	Leaman John Harold	director	Stock Option (right to buy)	A	14,150	$0.68	$9,622.00

Supply Chain of TRAW

RELATIONS

Upstream

Viriom, Inc.Temple UniversityExpert Systems Inc.Unnamed CDMOs (Contract Development & Manufacturing Organizations)HanX Biopharmaceuticals (Wuhan) Co., Ltd.HKEx:3378

Downstream

Knight Therapeutics Inc.TSX:GUDSpecialised Therapeutics Asia Pte Ltd.Pint Pharma International SA (Pint International SA)SymBio Pharmaceuticals LimitedTYO:4582

Proxies

Knight Therapeutics Inc.TSX:GUDHanX Biopharmaceuticals (Wuhan) Co., Ltd.HKEx:3378SymBio Pharmaceuticals LimitedTYO:4582Pfizer Inc.NYSE:PFERoche Holding AGSWX:ROG

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer